Skip to main content
Top
Published in: International Urology and Nephrology 3/2010

Open Access 01-09-2010 | Nephrology - Original Paper

Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy

Authors: Fengping Wang, Xisheng Xie, Junming Fan, Li Wang, Dongyang Guo, Lichuan Yang, Xiaofen Ma, Lina Zhang, Zi Li

Published in: International Urology and Nephrology | Issue 3/2010

Login to get access

Abstract

Background

In cultured NIH3T3 cells, P311 binds to the transforming growth factor-beta (TGF-β)-1 latency-associated protein (LAP) and induces the myofibroblast phenotype. In this study, we determined the levels of P311 and TGF-β1 proteins in tubulointerstitial tissue of patients with different severities of immunoglobulin-A nephropathy (IgAN), and analyzed the relationships between P311 protein expression and clinical data.

Methods

A total of 57 patients with IgAN and 5 controls (from partial nephrectomy) were included. P311 and TGF-β1 protein expression were measured by immunohistochemistry and clinical data (proteinuria, serum creatinine (Scr), eGFR and biopsy index) were recorded. The relationship between P311, TGF-β1, and clinical data was analyzed.

Results

P311 expression was significantly higher in the kidneys of IgAN patients than in controls and was higher in patients with advanced pathological grades of IgAN. P311 protein expression in tubulointerstitial tissue correlated with TGF-β1 and proteinuria. P311 expression was higher in patients with Scr > 133 μmol/L than in patients with Scr < 133 μmol/L.

Conclusion

P311 protein expression in the kidneys of IgAN patients correlates with TGF-β1 expression and with proteinuria. P311 might be a key cytokine in renal fibrosis and be involved in the progression of IgAN.
Literature
1.
go back to reference Eddy AA (1996) Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495–2508PubMed Eddy AA (1996) Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495–2508PubMed
2.
go back to reference Kiichiro J, David J, Lan HY et al (2001) Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38:761–769CrossRef Kiichiro J, David J, Lan HY et al (2001) Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38:761–769CrossRef
3.
go back to reference Tang W, Van G, Qi M (1997) Myofibroblast and α1 (III) collagen expression in experimental tubulointerstitial nephritis. Kidney Int 51:926–931CrossRefPubMed Tang W, Van G, Qi M (1997) Myofibroblast and α1 (III) collagen expression in experimental tubulointerstitial nephritis. Kidney Int 51:926–931CrossRefPubMed
4.
go back to reference Stauart G, Kimberley M, Aled O (2001) Regulation of renal proximal tubular epithelial cell fibroblast growth factor 2 generation by heparin. Am J Kidney Dis 38:597–609CrossRef Stauart G, Kimberley M, Aled O (2001) Regulation of renal proximal tubular epithelial cell fibroblast growth factor 2 generation by heparin. Am J Kidney Dis 38:597–609CrossRef
5.
go back to reference Zhang HY, Gharaee Kermani M, Zhang K et al (1996) Lung fibroblast alpha smooth muscle actin expression and contractile phenotype in bleomycin induced pulmonary fibrosis. Am J Pathol 148:527–537PubMed Zhang HY, Gharaee Kermani M, Zhang K et al (1996) Lung fibroblast alpha smooth muscle actin expression and contractile phenotype in bleomycin induced pulmonary fibrosis. Am J Pathol 148:527–537PubMed
6.
go back to reference Ponda M, Siconolfi L, Kopp J (2007) NAGL and Extracellular Matrix Proteins in TGF-β induced chronic renal fibrosis. Am J Kidney Dis 49:B66CrossRef Ponda M, Siconolfi L, Kopp J (2007) NAGL and Extracellular Matrix Proteins in TGF-β induced chronic renal fibrosis. Am J Kidney Dis 49:B66CrossRef
7.
go back to reference Hewitson TD, Wu H, Becker G (1995) Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 15:411–417CrossRefPubMed Hewitson TD, Wu H, Becker G (1995) Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 15:411–417CrossRefPubMed
8.
go back to reference Desmouliere A, Gabbiani G (1995) Myofibroblast differentiation during fibrosis. Exp Nephrol 3:134–139PubMed Desmouliere A, Gabbiani G (1995) Myofibroblast differentiation during fibrosis. Exp Nephrol 3:134–139PubMed
9.
go back to reference Masur SK, Dewal HS, Dinh TT et al (1996) Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci USA 93:4219–4223CrossRefPubMed Masur SK, Dewal HS, Dinh TT et al (1996) Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci USA 93:4219–4223CrossRefPubMed
10.
go back to reference Tang WW, Ulich TR, Lacey DL et al (1996) Platelet derived growth factor BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148:1169–1180PubMed Tang WW, Ulich TR, Lacey DL et al (1996) Platelet derived growth factor BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148:1169–1180PubMed
11.
go back to reference JunMing F, YeeYung N, Prudence A et al (1999) Transforming growth factor β regulates tubular epithelial myofibroblast transdifferentiation in vitro. Kidney Int 56:1455–1471CrossRef JunMing F, YeeYung N, Prudence A et al (1999) Transforming growth factor β regulates tubular epithelial myofibroblast transdifferentiation in vitro. Kidney Int 56:1455–1471CrossRef
12.
go back to reference Seema P, Jinghua S, Urimil D et al (2004) P311 binds to the latency associated protein and downregulates the expression of TGF-β1 and TGF-β2. Biochem Bioph Res Co 315:1104–1109CrossRef Seema P, Jinghua S, Urimil D et al (2004) P311 binds to the latency associated protein and downregulates the expression of TGF-β1 and TGF-β2. Biochem Bioph Res Co 315:1104–1109CrossRef
13.
go back to reference Pan D, Zhe X, Jakkaraju S et al (2002) P311 induces a TGF-β1 independent, nonfibrogenic myofibroblast phenotype. J Clin Invest 110(9):1349–1358PubMed Pan D, Zhe X, Jakkaraju S et al (2002) P311 induces a TGF-β1 independent, nonfibrogenic myofibroblast phenotype. J Clin Invest 110(9):1349–1358PubMed
14.
go back to reference Chauveau D, Droz D et al (1993) Follow up evalution of the first patients with IgA nephropathy described at Necker Hospital. Contrib Nephrol 104:1–5PubMed Chauveau D, Droz D et al (1993) Follow up evalution of the first patients with IgA nephropathy described at Necker Hospital. Contrib Nephrol 104:1–5PubMed
15.
go back to reference D’amico G (1987) The commonest glomerulonephritis in the world:IgA nephropathy. Quart J Med 64:709–727PubMed D’amico G (1987) The commonest glomerulonephritis in the world:IgA nephropathy. Quart J Med 64:709–727PubMed
16.
go back to reference Lee SM (1997) Prognostic indicators of progressive renal disease in IgA nephropathy: emergence of a new histologic grading system. Am J Kidney Dis 29:953–958CrossRefPubMed Lee SM (1997) Prognostic indicators of progressive renal disease in IgA nephropathy: emergence of a new histologic grading system. Am J Kidney Dis 29:953–958CrossRefPubMed
17.
go back to reference Haas M (1997) Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 29:829–842CrossRefPubMed Haas M (1997) Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 29:829–842CrossRefPubMed
18.
go back to reference Katafuchi R, Kiyoshi Y, Oh Y (1998) Glomerular score as prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol 49:1–8PubMed Katafuchi R, Kiyoshi Y, Oh Y (1998) Glomerular score as prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol 49:1–8PubMed
19.
go back to reference Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130:461–470PubMed Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130:461–470PubMed
20.
go back to reference Toyoda M, Suzuki D, Uimezono T et al (2002) High expression of connective tissue growth factor mRNA is an important factor in the pathogenesis of human IgA nephropathy. Nephrology 7:116–117CrossRef Toyoda M, Suzuki D, Uimezono T et al (2002) High expression of connective tissue growth factor mRNA is an important factor in the pathogenesis of human IgA nephropathy. Nephrology 7:116–117CrossRef
21.
go back to reference Angela MD, Francis WB (2006) Mesangial autoantigens in IgA nephropathy: matrix synthesis and localization. J Lab Clin Med 147:301–309CrossRef Angela MD, Francis WB (2006) Mesangial autoantigens in IgA nephropathy: matrix synthesis and localization. J Lab Clin Med 147:301–309CrossRef
22.
go back to reference Iwano M, Neilson EG et al (2004) Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 13(3):279–284CrossRefPubMed Iwano M, Neilson EG et al (2004) Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 13(3):279–284CrossRefPubMed
23.
go back to reference Sato M, Muragaki Y, Saika S et al (2003) Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112:1486–1494PubMed Sato M, Muragaki Y, Saika S et al (2003) Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112:1486–1494PubMed
24.
go back to reference Zhang Y, McCormick LL, Gilliam AC (2003) Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol 121:713–719CrossRefPubMed Zhang Y, McCormick LL, Gilliam AC (2003) Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol 121:713–719CrossRefPubMed
26.
go back to reference Pierre Jean W, Boris H (2008) Integrins and the activation of latent transforming growth factor β1-An intimate relationship. Eur J Cell Biol 87:601–615CrossRef Pierre Jean W, Boris H (2008) Integrins and the activation of latent transforming growth factor β1-An intimate relationship. Eur J Cell Biol 87:601–615CrossRef
Metadata
Title
Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy
Authors
Fengping Wang
Xisheng Xie
Junming Fan
Li Wang
Dongyang Guo
Lichuan Yang
Xiaofen Ma
Lina Zhang
Zi Li
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2010
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9681-3

Other articles of this Issue 3/2010

International Urology and Nephrology 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.